Published in Blood on January 12, 2016
Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. Cochrane Database Syst Rev (2016) 0.75
Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera. Intern Med (2017) 0.75
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med (1991) 13.21
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol (1992) 11.03
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med (2004) 10.51
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2013) 8.29
Hypoxia-inducible factors in physiology and medicine. Cell (2012) 8.16
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med (2002) 7.59
A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med (2011) 7.21
Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J (2009) 6.64
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA (2005) 6.49
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA (2005) 6.14
Sickle-cell disease. Lancet (2010) 5.64
Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2009) 5.31
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA (2014) 5.01
Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol (2013) 4.89
JNK signaling in apoptosis. Oncogene (2008) 4.72
Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation (2001) 4.38
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet (2002) 4.06
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol (2006) 3.02
Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur Respir J (2011) 2.85
Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation (2010) 2.85
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol (2007) 2.76
Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med (2007) 2.68
Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies. Haematologica (2005) 2.64
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood (2002) 2.60
Characterization of heme as activator of Toll-like receptor 4. J Biol Chem (2007) 2.38
Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol (2008) 2.32
Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood (2007) 2.31
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood (2007) 2.30
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med (2014) 2.23
Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica (2009) 2.20
Regulation of the erythropoietin gene. Blood (1999) 2.10
Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation (2003) 1.98
Causes of death in sickle cell disease: an autopsy study. Br J Haematol (2003) 1.96
Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol (2008) 1.93
Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells. Am J Pathol (2010) 1.79
Circumstances of death in adult sickle cell disease patients. Am J Hematol (2006) 1.74
Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Hum Pathol (2002) 1.73
The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica (2012) 1.72
Mortality in adults with sickle cell disease and pulmonary hypertension. JAMA (2012) 1.72
HIF and the lung: role of hypoxia-inducible factors in pulmonary development and disease. Am J Respir Crit Care Med (2011) 1.68
Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica (2008) 1.67
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood (2011) 1.64
The adventitia: a dynamic interface containing resident progenitor cells. Arterioscler Thromb Vasc Biol (2011) 1.58
Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J Clin Invest (2013) 1.58
Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. Eur J Echocardiogr (2011) 1.57
von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. J Clin Invest (2007) 1.56
Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol (2002) 1.52
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol (2005) 1.47
Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological. Cell Mol Life Sci (2009) 1.39
The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model. Blood (2010) 1.35
Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. Br J Haematol (2006) 1.34
Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea. Blood (2015) 1.33
Cardiovascular abnormalities in sickle cell disease. J Am Coll Cardiol (2012) 1.31
Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke (2006) 1.31
Pulmonary hypertension and NO in sickle cell. Blood (2010) 1.28
Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med (2008) 1.28
Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease. Blood (2015) 1.25
Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment. Am J Pathol (2011) 1.23
High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension. Blood (2010) 1.22
Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia. Haematologica (2010) 1.16
Hemodynamic predictors of mortality in adults with sickle cell disease. Am J Respir Crit Care Med (2013) 1.16
Mutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell disease. Am J Hematol (2008) 1.15
Sickle cell lung disease and sudden death: a retrospective/prospective study of 21 autopsy cases and literature review. Am J Forensic Med Pathol (2007) 1.13
Hemostatic abnormalities in sickle cell disease. Curr Opin Hematol (2013) 1.08
Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease. Br J Haematol (2009) 1.03
Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Am J Respir Crit Care Med (1998) 0.98
Signal transduction in the development of pulmonary arterial hypertension. Pulm Circ (2013) 0.95
Pulmonary artery pressure and iron deficiency in patients with upregulation of hypoxia sensing due to homozygous VHL(R200W) mutation (Chuvash polycythemia). Haematologica (2011) 0.94
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol (2014) 0.94
Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease. Circulation (2014) 0.92
Mechanistic insights and characterization of sickle cell disease-associated cardiomyopathy. Circ Cardiovasc Imaging (2014) 0.92
Splenectomy is modifying the vascular remodeling of thrombosis. J Am Heart Assoc (2014) 0.92
Association of anemia and long-term survival in patients with pulmonary hypertension. Int J Cardiol (2010) 0.90
Balancing role of nitric oxide in complement-mediated activation of platelets from mCd59a and mCd59b double-knockout mice. Am J Hematol (2009) 0.87
Revisiting the hyperhemolysis paradigm. Blood (2015) 0.86
Chronic thromboembolic pulmonary hypertension: a distinct disease entity. Eur Respir Rev (2015) 0.82
Exercise-Induced Abnormal Increase of Systolic Pulmonary Artery Pressure in Adult Patients With Sickle Cell Anemia: An Exercise Stress Echocardiography Study. Echocardiography (2014) 0.78
Pulmonary endarterectomy in sickle cell haemoglobin C disease. Eur Respir J (2011) 0.77
First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease. Pulm Circ (2013) 0.77
Pulmonary endarterectomy: part I. Pathophysiology, clinical manifestations, and diagnostic evaluation of chronic thromboembolic pulmonary hypertension. Semin Cardiothorac Vasc Anesth (2014) 0.76
Cardiopulmonary bypass with deep hypothermic circulatory arrest for a patient with sickle cell anemia: a case report. J Extra Corpor Technol (2001) 0.76
Pulmonary endarterectomy as treatment for chronic thromboembolic pulmonary hypertension in sickle cell disease. Am J Hematol (2015) 0.76
Regular automated red cell exchange transfusion in the management of pulmonary hypertension in sickle cell disease. Br J Haematol (2014) 0.76
Successful pulmonary thromboendarterectomy in a patient with sickle cell disease treated with a single preoperative red blood cell exchange. Transfusion (2014) 0.75